Global Grand Challenges: Innovations in Eliminating Neglected Tropical Diseases

Funding Agency:
Gates (Bill & Melinda) Foundation

The elimination of neglected tropical diseases (NTDs) is feasible but its progress is hindered by the suboptimal implementation of available interventions. Challenges faced by NTD programs can range from poor targeting of interventions, low treatment coverage among specific sub-groups, and lack of surveillance systems that can meet the sensitivity and specificity requirements for the endgame of disease elimination. These challenges could be addressed by the development of innovative solutions but also by the application of existing tools and technologies which are effectively used by other health programs, including polio, malaria and immunization. We see an opportunity to identify and demonstrate feasibility of innovative solutions and new applications of existing technologies to address the challenges faced by national NTD programs in mapping, targeting, disease and vector surveillance, and other endgame strategies.

We have partnered with Kikundi, a community of practice for NTD program managers in Africa, to identify areas for transformational innovation in service of national NTD programs. We invite proposals that will address one or more of the following areas:

  • Methods to rapidly map NTDs, including integrated mapping
  • Methods to better target existing interventions
  • Strategies to target subgroups routinely missed by programs
  • Approaches to vector surveillance
  • Integrated surveillance that leverages other health surveillance platforms
  • Strategies for post-elimination surveillance, including cross-border surveillance.

Deadline; Jan. 13, 2022

Agency Website

Amount Description

Funding level: up to USD $200,000 for each project, with a grant term of up to 24 months depending on the scope of the project.

Funding Type





International Opportunities
Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

January 13, 2022